A comparison of antiarrhythmic effect of pindolol and propranolol in experimental cardiac arrhythmias. 1979

R K Soni, and V K Pendse, and V S Acharya, and V Soni

UI MeSH Term Description Entries
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

R K Soni, and V K Pendse, and V S Acharya, and V Soni
October 1969, British journal of pharmacology,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
April 1986, Yao xue xue bao = Acta pharmaceutica Sinica,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
January 1985, Journal of pharmacobio-dynamics,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
May 1971, British journal of pharmacology,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
December 1967, Anglo-German medical review. Deutsch-englische medizinische Rundschau,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
April 1983, The American journal of cardiology,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
February 1983, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
November 1983, The American journal of cardiology,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
January 1972, The Journal of clinical pharmacology and new drugs,
R K Soni, and V K Pendse, and V S Acharya, and V Soni
December 1969, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!